Discover why LeMaitre's expansion in the peripheral vascular disease market and strong dividend growth make it an appealing ...
A recently unsealed lawsuit alleges sales reps from Medtronic, the world’s largest medical equipment company, operated a bribery scheme at a Kansas hospital.
Medtronic and Volcano Corporation. Peripheral vascular devices Market Outlook Peripheral vascular devices are gadgets used in the diagnosis and management of diseases of the blood vessels other ...
Medtronic announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.
Zacks.com on MSN3d
Medtronic Stock Trading at a Discount Before Q2 Earnings: Time to Buy?Medtronic plc MDT is scheduled to report second-quarter fiscal 2025 results on Nov. 19, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1.23 exceeded the ...
Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...
The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in ...
About a year ago, renal denervation procedures won a huge victory after finally being greenlit by FDA. Now two of the frontrunners in the space have received reimbursement.
A pediatric arterial filter for the most magical patients, the Affinity Pixie arterial filter features ease of prime and effective air handling and filtration. The filter’s maximum recommended ...
The Peripheral Vascular devices market is fragmented. A few strong players in this market are Boston Scientific Corporation (U.S.), Medtronic (U.S), Philips (Japan), Merit Medical Systems (U.S ...
Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Lemaitre Vascular (LMAT – Research Report) today and set a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback